- Home
- HUMAW vs OPK Comparison
HUMAW vs OPK Comparison
Compare HUMAW & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMAW
- OPK
- Stock Information
- Founded
- HUMAW 2004
- OPK 2007
- Country
- HUMAW United States
- OPK United States
- Employees
- HUMAW 220
- OPK N/A
- Industry
- HUMAW Biotechnology: Pharmaceutical Preparations
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- HUMAW Health Care
- OPK Health Care
- Exchange
- HUMAW Nasdaq
- OPK Nasdaq
- Market Cap
- HUMAW N/A
- OPK N/A
- IPO Year
- HUMAW N/A
- OPK 1995
- Fundamental
- Price
- HUMAW $0.49
- OPK $1.33
- Analyst Decision
- HUMAW
- OPK Buy
- Analyst Count
- HUMAW 0
- OPK 4
- Target Price
- HUMAW N/A
- OPK $2.75
- AVG Volume (30 Days)
- HUMAW 14.2K
- OPK 3.4M
- Earning Date
- HUMAW 03-21-2025
- OPK 04-30-2025
- Dividend Yield
- HUMAW N/A
- OPK N/A
- EPS Growth
- HUMAW N/A
- OPK N/A
- EPS
- HUMAW N/A
- OPK N/A
- Revenue
- HUMAW N/A
- OPK $689,408,000.00
- Revenue This Year
- HUMAW N/A
- OPK N/A
- Revenue Next Year
- HUMAW N/A
- OPK $8.11
- P/E Ratio
- HUMAW N/A
- OPK N/A
- Revenue Growth
- HUMAW N/A
- OPK N/A
- 52 Week Low
- HUMAW $1.18
- OPK $1.15
- 52 Week High
- HUMAW $1.34
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- HUMAW N/A
- OPK 43.81
- Support Level
- HUMAW N/A
- OPK $1.21
- Resistance Level
- HUMAW N/A
- OPK $1.33
- Average True Range (ATR)
- HUMAW 0.00
- OPK 0.07
- MACD
- HUMAW 0.00
- OPK 0.01
- Stochastic Oscillator
- HUMAW 0.00
- OPK 52.17
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.